Skip to content
Search

Latest Stories

Prof James Kingsland steps down from NAPC board

A founding member of the National Association of Primary Care (NAPC) - Professor James Kingsland OBE - announced he is to step down as an NAPC Director at the end of March after more than 20 years.

Kingsland joined the association's executive board since its inception and was part of the board of NAPC’s predecessor, the National Association of Fundholding Practices.


Prof Kingsland led the NAPC as its chair for four years from September 2004 and went on to become president of the organisation for 11 years until September 2019.

NAPC Chair Minesh Patel said: “James has played a pivotal role in NAPC over the last 20 years championing reform and steering the direction of the organisation. Most recently he was one of the architects of the primary care home model which subsequently influenced primary care network policy. His knowledge and expertise will be very much missed.”

Prof Kingsland, a GP on the Wirral since 1989, was instrumental in the development and implementation of Personalised Medical Services (PMS) policy in the late 1990s. He helped to lead the development of Practice-Based Commissioning while working as an advisor at the Department of Health.

He became an advisor to Lord Darzi in October 2007 and was appointed an Officer of the Order of the British Empire in the Queen’s Diamond Jubilee New Year Honours List in 2012.

“It is going to be strange not working with the NAPC as it has been a part of my career for the last 20 years,” said Prof Kingsland.

“I am really proud of what the NAPC has achieved since its creation and I’ve been privileged to work with such spirited and hugely talented people in the organisation.

“I leave the NAPC as the established voice of integrated primary care providers and look forward to now watching its ever-increasing role and influence in the betterment of integrated care provision,” he added.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less